Benjamin T. Dake

Insider Reports History

Entity
Individual
Location
C/O Aerovate Therapeutics, Inc., 200 Berkeley Street, Floor 18, Boston, MA
Signature
/s/ George A. Eldridge, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Benjamin T. Dake:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Aerovate Therapeutics, Inc. Officer Title: President, Chief Operating Officer and Secretary Common Stock 14.3K $24.8K $1.74 Aug 1, 2024 Direct
Aerovate Therapeutics, Inc. Officer Title: President, Chief Operating Officer and Secretary Stock Option (Right to Buy) 0 $0 $16.37 Aug 1, 2024 Direct

Insider Reports Filed by Benjamin T. Dake

Symbol Company Period Transactions Value $ Form Type Date Filed Role
AVTE Aerovate Therapeutics, Inc. Jul 31, 2024 5 $22.6K 4 Aug 2, 2024 Officer Title: President, Chief Operating Officer and Secretary
AVTE Aerovate Therapeutics, Inc. Apr 17, 2024 5 -$139K 4 Apr 19, 2024 Officer Title: President, Chief Operating Officer and Secretary
AVTE Aerovate Therapeutics, Inc. Apr 1, 2024 3 -$71K 4 Apr 3, 2024 Officer Title: President, Chief Operating Officer and Secretary
AVTE Aerovate Therapeutics, Inc. Mar 27, 2024 3 -$192K 4 Mar 28, 2024 Officer Title: President, Chief Operating Officer and Secretary
AVTE Aerovate Therapeutics, Inc. Mar 25, 2024 3 -$59.7K 4 Mar 27, 2024 Officer Title: President, Chief Operating Officer and Secretary
AVTE Aerovate Therapeutics, Inc. Mar 18, 2024 6 -$710K 4 Mar 20, 2024 Officer Title: President, Chief Operating Officer and Secretary
AVTE Aerovate Therapeutics, Inc. Jan 22, 2024 1 $0 4 Jan 24, 2024 Officer Title: President, Chief Operating Officer and Secretary
AVTE Aerovate Therapeutics, Inc. Dec 6, 2023 7 -$145K 4 Dec 7, 2023 Officer Title: President, Chief Operating Officer and Secretary
AVTE Aerovate Therapeutics, Inc. Nov 27, 2023 7 -$177K 4 Nov 29, 2023 Officer Title: President, Chief Operating Officer and Secretary
AVTE Aerovate Therapeutics, Inc. Nov 22, 2023 12 -$191K 4 Nov 27, 2023 Officer Title: President, Chief Operating Officer and Secretary
AVTE Aerovate Therapeutics, Inc. Sep 6, 2023 10 -$52.1K 4 Sep 8, 2023 Officer Title: President, Chief Operating Officer and Secretary
AVTE Aerovate Therapeutics, Inc. Aug 7, 2023 8 -$139K 4 Aug 9, 2023 Officer Title: President, Chief Operating Officer and Secretary
AVTE Aerovate Therapeutics, Inc. Jul 6, 2023 7 -$150K 4 Jul 7, 2023 Officer Title: President, Chief Operating Officer and Secretary
AVTE Aerovate Therapeutics, Inc. Jun 6, 2023 8 -$146K 4 Jun 8, 2023 Officer Title: President, Chief Operating Officer and Secretary
AVTE Aerovate Therapeutics, Inc. May 8, 2023 8 -$203K 4 May 9, 2023 Officer Title: President, Chief Operating Officer and Secretary
AVTE Aerovate Therapeutics, Inc. Apr 6, 2023 7 -$166K 4 Apr 7, 2023 Officer Title: President, Chief Operating Officer and Secretary
AVTE Aerovate Therapeutics, Inc. Mar 6, 2023 8 -$223K 4 Mar 8, 2023 Officer Title: President, Chief Operating Officer and Secretary
AVTE Aerovate Therapeutics, Inc. Feb 6, 2023 9 -$232K 4 Feb 8, 2023 Officer Title: President, Chief Operating Officer and Secretary
AVTE Aerovate Therapeutics, Inc. Jan 6, 2023 8 -$246K 4 Jan 9, 2023 Officer Title: President, Chief Operating Officer and Secretary
AVTE Aerovate Therapeutics, Inc. Dec 12, 2022 5 -$56.2K 4 Dec 14, 2022 Officer Title: President, Chief Operating Officer and Secretary
AVTE Aerovate Therapeutics, Inc. Dec 8, 2022 9 -$214K 4 Dec 12, 2022 Officer Title: President, Chief Operating Officer and Secretary
AVTE Aerovate Therapeutics, Inc. Dec 6, 2022 10 -$622K 4 Dec 8, 2022 Officer Title: President, Chief Operating Officer and Secretary
AVTE Aerovate Therapeutics, Inc. Nov 9, 2022 11 -$368K 4 Nov 14, 2022 Officer Title: President, Chief Operating Officer and Secretary
AVTE Aerovate Therapeutics, Inc. Nov 7, 2022 13 -$420K 4 Nov 9, 2022 Officer Title: President, Chief Operating Officer and Secretary
AVTE Aerovate Therapeutics, Inc. Oct 18, 2022 3 -$108K 4 Oct 20, 2022 Officer Title: President, Chief Operating Officer and Secretary
AVTE Aerovate Therapeutics, Inc. Oct 14, 2022 6 -$77.4K 4 Oct 18, 2022 Officer Title: President, Chief Operating Officer and Secretary
AVTE Aerovate Therapeutics, Inc. Oct 10, 2022 4 -$73.1K 4 Oct 12, 2022 Officer Title: President, Chief Operating Officer and Secretary
AVTE Aerovate Therapeutics, Inc. Oct 6, 2022 13 -$325K 4 Oct 11, 2022 Officer Title: President, Chief Operating Officer and Secretary
AVTE Aerovate Therapeutics, Inc. Sep 12, 2022 5 -$114K 4 Sep 14, 2022 Officer Title: President, Chief Operating Officer and Secretary
AVTE Aerovate Therapeutics, Inc. Sep 8, 2022 11 -$124K 4 Sep 12, 2022 Officer Title: President, Chief Operating Officer and Secretary
AVTE Aerovate Therapeutics, Inc. Sep 6, 2022 9 -$207K 4 Sep 8, 2022 Officer Title: President, Chief Operating Officer and Secretary
AVTE Aerovate Therapeutics, Inc. Aug 16, 2022 6 -$446K 4 Aug 18, 2022 Officer Title: President, Chief Operating Officer and Secretary
AVTE Aerovate Therapeutics, Inc. Aug 10, 2022 8 -$314K 4 Aug 12, 2022 Officer Title: President, Chief Operating Officer and Secretary
AVTE Aerovate Therapeutics, Inc. Aug 8, 2022 8 -$353K 4 Aug 10, 2022 Officer Title: President, Chief Operating Officer and Secretary
AVTE Aerovate Therapeutics, Inc. Dec 14, 2021 1 $0 4 Dec 16, 2021 Officer Title: President, Chief Operating Officer and Secretary
AVTE Aerovate Therapeutics, Inc. Jun 29, 2021 0 $0 3 Jun 29, 2021 Officer Title: President, Chief Operating Officer and Secretary Exhibit 24 - Power of Attorney
AVTE Aerovate Therapeutics, Inc. Apr 2, 2021 3 $0 4 Jul 1, 2021 Officer Title: President, Chief Operating Officer and Secretary